Order Article Reprints

Mittal NK, Mandal B, Balabathula P, Setua S, Janagam DR, Lothstein L, Thoma LA, Wood GC. Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics. 2018; 10(2):50. https://doi.org/10.3390/pharmaceutics10020050

Mittal, Nivesh K., Bivash Mandal, Pavan Balabathula, Saini Setua, Dileep R. Janagam, Leonard Lothstein, Laura A. Thoma, and George C. Wood. 2018. "Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies" Pharmaceutics 10, no. 2: 50. https://doi.org/10.3390/pharmaceutics10020050

Mittal, N. K., Mandal, B., Balabathula, P., Setua, S., Janagam, D. R., Lothstein, L., Thoma, L. A., & Wood, G. C. (2018). Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics, 10(2), 50. https://doi.org/10.3390/pharmaceutics10020050